Rabeprazole Sodium

Images are for illustration purposes only;
actual packaging may vary.

Rabeprazole Sodium is a proton pump inhibitor (PPI) that effectively reduces stomach acid production, making it a valuable component in the management of gastroesophageal reflux disease (GERD), Zollinger-Ellison syndrome, and other acid-related disorders. By inhibiting the H+/K+ ATPase enzyme system in the gastric parietal cells, Rabeprazole Sodium provides relief from symptoms such as heartburn, acid reflux, and esophageal irritation.

Its rapid onset of action and sustained efficacy make it a preferred choice for both acute and maintenance therapy in acid-related conditions. Rabeprazole Sodium is often utilized in compounded formulations to tailor treatment to individual patient needs, ensuring optimal therapeutic outcomes. Its safety profile and effectiveness have been well-documented, making it a reliable option for prescribers seeking to manage acid-related gastrointestinal issues.

Trusted by 60,357 patients to date.

A group of faces of our past satisfied patients.

Custom made in our compounding labs.

Personalized treatment for better results.

All strengths and ingredients are tailored to your needs.

This medication is not available at retail pharmacies. It is compounded, and may be more effective at treating you or your patient.

This is some text inside of a div block.

Heading 1

Heading 2

Heading 3

Heading 4

Heading 5

Heading 6

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.

Block quote

Ordered list

Item 1
Item 2
Item 3

Unordered list

Item A
Item B
Item C

Text link

Bold text

Emphasis

^Superscript

_Subscript

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

Active Ingredient Information

Rabeprazole Sodium is a proton pump inhibitor (PPI) that effectively reduces gastric acid secretion by inhibiting the H+/K+ ATPase enzyme system at the secretory surface of the gastric parietal cell. This mechanism of action makes it a valuable therapeutic agent in the management of conditions such as gastroesophageal reflux disease (GERD), Zollinger-Ellison syndrome, and peptic ulcer disease.

As a highly selective and potent PPI, Rabeprazole Sodium provides rapid relief from acid-related symptoms and promotes healing of the gastric and duodenal mucosa. Its pharmacokinetic profile is characterized by a rapid absorption with peak plasma concentrations typically achieved within 3.5 hours post-administration, and it exhibits a half-life of approximately 1 to 2 hours.

Rabeprazole Sodium is metabolized primarily in the liver through non-enzymatic reduction and cytochrome P450-mediated oxidation, with its metabolites excreted via urine and feces. This API is generally well-tolerated, with a safety profile that supports its use in both short-term and long-term treatment regimens.

Common side effects may include headache, diarrhea, and nausea, but these are typically mild and transient. Rabeprazole Sodium's efficacy and safety make it a preferred choice for prescribers aiming to manage acid-related disorders effectively, ensuring improved patient outcomes and quality of life.

Formulas using

Rabeprazole Sodium

Formulas and/or material listed are not to be interpreted as a promise, guarantee or claim of therapeutic efficacy or safety. The information contained herein is not intended to replace or substitute for conventional medical care, or encourage its abandonment. Every patient is unique, and formulas should be adjusted to meet their individual needs.

No compounded medications are reviewed by the FDA for safety or efficacy.